{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T07:29:59Z","timestamp":1792740599472,"version":"4.5.0"},"reference-count":276,"publisher":"Informa UK Limited","issue":"12","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["vaccines"],"published-print":{"date-parts":[[2013,12,1]]},"DOI":"10.4161\/hv.26109","type":"journal-article","created":{"date-parts":[[2013,9,11]],"date-time":"2013-09-11T19:27:14Z","timestamp":1378927634000},"page":"2505-2523","source":"Crossref","is-referenced-by-count":252,"title":["Protein carriers of conjugate vaccines: Characteristics, development and clinical trials"],"prefix":"10.1080","volume":"9","author":[{"given":"Michael E","family":"Pichichero","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","reference":[{"key":"R1","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1093\/infdis\/138.4.427","article-title":"Role of immunity in the clearance of bacteremia due to Haemophilus influenzae","volume":"138","author":"Weller","year":"1978","journal-title":"J Infect Dis"},{"key":"R2","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1111\/j.1365-2567.2004.01971.x","article-title":"Haemophilus influenzae type b conjugate vaccines","volume":"113","author":"Kelly","year":"2004","journal-title":"Immunology"},{"key":"R3","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/S0167-7012(01)00290-1","article-title":"Novel vaccine strategies to T-independent antigens","volume":"47","author":"Lesinski","year":"2001","journal-title":"J Microbiol Methods"},{"key":"R4","unstructured":"Landsteiner K. The specificity of serologic reactions. Cambridge, Mass: Harvard University Press 2013."},{"key":"R5","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1084\/jem.50.4.533","article-title":"CHEMO-IMMUNOLOGICAL STUDIES ON CONJUGATED CARBOHYDRATE-PROTEINS : II. IMMUNOLOGICAL SPECIFICITY OF SYNTHETIC SUGAR-PROTEIN ANTIGENS","volume":"50","author":"Avery","year":"1929","journal-title":"J Exp Med"},{"key":"R6","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1084\/jem.152.2.361","article-title":"Preparation, characterization, and immunogenicity of Haemophilus influenzae type b polysaccharide-protein conjugates","volume":"152","author":"Schneerson","year":"1980","journal-title":"J Exp Med"},{"key":"R7","doi-asserted-by":"crossref","first-page":"289A","DOI":"10.1203\/00006450-198404001-01178","article-title":"Augmented antibody (Ab) responses in infants administered a new Haemophilus influenzae type b capsular polysaccharide (PRP) diphtheria toxoid conjugate vaccine (PRP-D)","volume":"18","author":"Zahradnik","year":"1984","journal-title":"Pediatr Res"},{"key":"R8","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.4049\/jimmunol.137.4.1181","article-title":"Vaccines consisting of periodate-cleaved oligosaccharides from the capsule of Haemophilus influenzae type b coupled to a protein carrier: structural and temporal requirements for priming in the human infant","volume":"137","author":"Anderson","year":"1986","journal-title":"J Immunol"},{"key":"R9","doi-asserted-by":"crossref","first-page":"5282","DOI":"10.1021\/ja00277a037","article-title":"Bimolecular Chemistry of Macromolecules: Synthesis of Bacterial Polysaccharide Conjugates with Neisseria meningitidis Membrane Protein","volume":"108","author":"Marburg","year":"1986","journal-title":"J Am Chem Soc"},{"key":"R10","doi-asserted-by":"crossref","first-page":"4063","DOI":"10.1093\/nar\/12.10.4063","article-title":"The amino-acid sequence of two non-toxic mutants of diphtheria toxin: CRM45 and CRM197","volume":"12","author":"Giannini","year":"1984","journal-title":"Nucleic Acids Res"},{"key":"R11","unstructured":"Comvax\u00ae[Haemophilus b Conjugate (Meningococcal Protein Conjugate) and Hepatitis B (Recombinant) Vaccine]. Merck & Co, Inc 2001."},{"key":"R12","unstructured":"Menactra Meningococcal. (Groups A, C, Y and W-135) Polysaccharide Diptheria Toxoid Conjugate Vaccine. Sanofi Pasteur 2008."},{"key":"R13","doi-asserted-by":"crossref","first-page":"3379","DOI":"10.4049\/jimmunol.145.10.3379","article-title":"Protein D of Haemophilus influenzae. A novel bacterial surface protein with affinity for human IgD","volume":"145","author":"Ruan","year":"1990","journal-title":"J Immunol"},{"key":"R14","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1172\/JCI111976","article-title":"Immunogens consisting of oligosaccharides from the capsule of Haemophilus influenzae type b coupled to diphtheria toxoid or the toxin protein CRM197","volume":"76","author":"Anderson","year":"1985","journal-title":"J Clin Invest"},{"key":"R15","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1093\/infdis\/152.3.634","article-title":"Capsular antigens noncovalently or covalently associated with protein as vaccines to Haemophilus influenzae type b: comparison in two-year-old children","volume":"152","author":"Anderson","year":"1985","journal-title":"J Infect Dis"},{"key":"R16","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/S0022-3476(85)80504-7","article-title":"Immunization of 2-month-old infants with protein-coupled oligosaccharides derived from the capsule of Haemophilus influenzae type b","volume":"107","author":"Anderson","year":"1985","journal-title":"J Pediatr"},{"key":"R17","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.4049\/jimmunol.137.4.1181","article-title":"Vaccines consisting of periodate-cleaved oligosaccharides from the capsule of Haemophilus influenzae type b coupled to a protein carrier: structural and temporal requirements for priming in the human infant","volume":"137","author":"Anderson","year":"1986","journal-title":"J Immunol"},{"key":"R18","doi-asserted-by":"crossref","first-page":"2464","DOI":"10.4049\/jimmunol.142.7.2464","article-title":"Effect of oligosaccharide chain length, exposed terminal group, and hapten loading on the antibody response of human adults and infants to vaccines consisting of Haemophilus influenzae type b capsular antigen unterminally coupled to the diphtheria protein CRM197","volume":"142","author":"Anderson","year":"1989","journal-title":"J Immunol"},{"key":"R19","doi-asserted-by":"crossref","first-page":"S160","DOI":"10.1093\/infdis\/165-Supplement_1-S160","article-title":"Effect of phosphate ester residues on the immunogenicity of CRM197-coupled Haemophilus influenzae type b capsular saccharides in 2-month-old infants","volume":"165","author":"Anderson","year":"1992","journal-title":"J Infect Dis"},{"key":"R20","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1128\/IAI.52.2.519-528.1986","article-title":"Quantitative and qualitative analyses of serum antibodies elicited in adults by Haemophilus influenzae type b and pneumococcus type 6A capsular polysaccharide-tetanus toxoid conjugates","volume":"52","author":"Schneerson","year":"1986","journal-title":"Infect Immun"},{"key":"R21","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1016\/S0022-3476(05)80655-9","article-title":"Duration of serum antibodies elicited by Haemophilus influenzae type b capsular polysaccharide alone or conjugated to tetanus toxoid in 18- to 23-month-old children","volume":"116","author":"Claesson","year":"1990","journal-title":"J Pediatr"},{"key":"R22","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1097\/00006454-199108000-00002","article-title":"Persistence of serum antibodies elicited by Haemophilus influenzae type b-tetanus toxoid conjugate vaccine in infants vaccinated at 3, 5 and 12 months of age","volume":"10","author":"Claesson","year":"1991","journal-title":"Pediatr Infect Dis J"},{"key":"R23","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/S0140-6736(86)90001-2","article-title":"Immunogenicity in infants of Haemophilus influenzae type B polysaccharide in a conjugate vaccine with Neisseria meningitidis outer-membrane protein","volume":"2","author":"Einhorn","year":"1986","journal-title":"Lancet"},{"key":"R24","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/S0022-3476(87)80336-0","article-title":"Immunologic priming to capsular polysaccharide in infants immunized with Haemophilus influenzae type b polysaccharide-Neisseria meningitidis outer membrane protein conjugate vaccine","volume":"111","author":"Weinberg","year":"1987","journal-title":"J Pediatr"},{"key":"R25","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1542\/peds.80.2.283","article-title":"Immunogenicity of Haemophilus influenzae type b polysaccharide-Neisseria meningitidis outer membrane protein conjugate vaccine in 2- to 6-month-old infants","volume":"80","author":"Lenoir","year":"1987","journal-title":"Pediatrics"},{"key":"R26","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1093\/infdis\/150.3.402","article-title":"Safety and immunogenicity of Haemophilus influenzae type B polysaccharide-diphtheria toxoid conjugate vaccine in adults","volume":"150","author":"Lepow","year":"1984","journal-title":"J Infect Dis"},{"key":"R27","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/S0022-3476(84)80350-9","article-title":"Immunogenicity of Haemophilus influenzae type b polysaccharide--diphtheria toxoid conjugate vaccine in adults","volume":"105","author":"Granoff","year":"1984","journal-title":"J Pediatr"},{"key":"R28","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/S0022-3476(85)80284-5","article-title":"Safety and immunogenicity of Haemophilus influenzae type b-polysaccharide diphtheria toxoid conjugate vaccine in infants 9 to 15 months of age","volume":"106","author":"Lepow","year":"1985","journal-title":"J Pediatr"},{"key":"R29","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/S0022-3476(87)80540-1","article-title":"Safety and immunogenicity of Haemophilus influenzae type b polysaccharide and polysaccharide diphtheria toxoid conjugate vaccines in children 15 to 24 months of age","volume":"110","author":"Berkowitz","year":"1987","journal-title":"J Pediatr"},{"key":"R30","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1056\/NEJM198709173171201","article-title":"Efficacy of Haemophilus influenzae type b polysaccharide-diphtheria toxoid conjugate vaccine in infancy","volume":"317","author":"Eskola","year":"1987","journal-title":"N Engl J Med"},{"key":"R31","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1056\/NEJM199011153232004","article-title":"A randomized, prospective field trial of a conjugate vaccine in the protection of infants and young children against invasive Haemophilus influenzae type b disease","volume":"323","author":"Eskola","year":"1990","journal-title":"N Engl J Med"},{"key":"R32","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.1056\/NEJM199106203242503","article-title":"The efficacy in Navajo infants of a conjugate vaccine consisting of Haemophilus influenzae type b polysaccharide and Neisseria meningitidis outer-membrane protein complex","volume":"324","author":"Santosham","year":"1991","journal-title":"N Engl J Med"},{"key":"R33","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1016\/0140-6736(92)92719-V","article-title":"Efficacy of Haemophilus influenzae type B conjugate vaccine in Oxford region","volume":"340","author":"Booy","year":"1992","journal-title":"Lancet"},{"key":"R34","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1016\/S0140-6736(96)09267-7","article-title":"Randomised trial of Haemophilus influenzae type-b tetanus protein conjugate vaccine [corrected] for prevention of pneumonia and meningitis in Gambian infants","volume":"349","author":"Mulholland","year":"1997","journal-title":"Lancet"},{"key":"R35","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1001\/archpedi.1994.02170060074015","article-title":"Clinical comparison of the Haemophilus influenzae type B polysaccharide-diphtheria toxoid and the oligosaccharide-CRM197 protein vaccines in infancy","volume":"148","author":"Peltola","year":"1994","journal-title":"Arch Pediatr Adolesc Med"},{"key":"R36","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1016\/j.vaccine.2004.06.052","article-title":"Dose response of CRM197 and tetanus toxoid-conjugated Haemophilus influenzae type b vaccines","volume":"23","author":"Huebner","year":"2004","journal-title":"Vaccine"},{"key":"R37","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1016\/j.vaccine.2004.09.028","article-title":"Double-blind study comparing the immunogenicity of a licensed DTwPHib-CRM197 conjugate vaccine (Quattvaxem) with three investigational, liquid formulations using lower doses of Hib-CRM197 conjugate","volume":"23","author":"Tamm","year":"2005","journal-title":"Vaccine"},{"key":"R38","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1097\/00006454-200204000-00019","article-title":"Safety, tolerability and immunogenicity of low dose Haemophilus influenzae type b conjugated to the outer membrane protein complex of Neisseria meningitidis group B","volume":"21","author":"Anderson","year":"2002","journal-title":"Pediatr Infect Dis J"},{"key":"R39","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/S0022-3476(96)70364-5","article-title":"Comparison of five different vaccination schedules with Haemophilus influenzae type b-tetanus toxoid conjugate vaccine","volume":"128","author":"Kurikka","year":"1996","journal-title":"J Pediatr"},{"key":"R40","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1097\/00006454-200210000-00019","article-title":"Dose escalation, safety and immunogenicity study of a tetravalent meninogococcal polysaccharide diphtheria conjugate vaccine in toddlers","volume":"21","author":"Rennels","year":"2002","journal-title":"Pediatr Infect Dis J"},{"key":"R41","doi-asserted-by":"crossref","first-page":"e276","DOI":"10.1097\/INF.0b013e3181b48ca3","article-title":"Immunogenicity of a 2-dose priming and booster vaccination with the 10-valent pneumococcal nontypeable Haemophilus influenzae protein D conjugate vaccine","volume":"28","author":"Silfverdal","year":"2009","journal-title":"Pediatr Infect Dis J"},{"key":"R42","doi-asserted-by":"crossref","first-page":"e15","DOI":"10.1097\/INF.0b013e31823e1e34","article-title":"A randomized trial to assess safety and immunogenicity of alternative formulations of a quadrivalent meningococcal (A, C, Y, and W-135) tetanus protein conjugate vaccine in toddlers","volume":"31","author":"McVernon","year":"2012","journal-title":"Pediatr Infect Dis J"},{"key":"R43","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1093\/infdis\/164.6.1154","article-title":"Serum anticapsular antibody response in the first week after immunization of adults and infants with the Haemophilus influenzae type b-Neisseria meningitidis outer membrane protein complex conjugate vaccine","volume":"164","author":"Daum","year":"1991","journal-title":"J Infect Dis"},{"key":"R44","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1097\/01.inf.0000207483.60267.e7","article-title":"Immunogenicity and boosting after a reduced number of doses of a pneumococcal conjugate vaccine in infants and toddlers","volume":"25","author":"Goldblatt","year":"2006","journal-title":"Pediatr Infect Dis J"},{"key":"R45","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1017\/S0950268812000957","article-title":"Dose-specific efficacy of Haemophilus influenzae type b conjugate vaccines: a systematic review and meta-analysis of controlled clinical trials","volume":"140","author":"Griffiths","year":"2012","journal-title":"Epidemiol Infect"},{"key":"R46","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/S0022-3476(05)81186-2","article-title":"Differences in the immunogenicity of three Haemophilus influenzae type b conjugate vaccines in infants","volume":"121","author":"Granoff","year":"1992","journal-title":"J Pediatr"},{"key":"R47","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/S0022-3476(05)80424-X","article-title":"Comparative trial in infants of four conjugate Haemophilus influenzae type b vaccines","volume":"120","author":"Decker","year":"1992","journal-title":"J Pediatr"},{"key":"R48","first-page":"223","article-title":"Antibody responses to four Haemophilus influenzae type b conjugate vaccines","volume":"145","author":"K\u00e4yhty","year":"1991","journal-title":"Am J Dis Child"},{"key":"R49","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1097\/00006454-199306000-00006","article-title":"Comparative immunogenicity of four Haemophilus influenzae type b conjugate vaccines in Alaska Native infants","volume":"12","author":"Bulkow","year":"1993","journal-title":"Pediatr Infect Dis J"},{"key":"R50","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1056\/NEJM199011153232006","article-title":"Limited efficacy of a Haemophilus influenzae type b conjugate vaccine in Alaska Native infants. The Alaska H. influenzae Vaccine Study Group","volume":"323","author":"Ward","year":"1990","journal-title":"N Engl J Med"},{"key":"R51","doi-asserted-by":"crossref","first-page":"e421","DOI":"10.1542\/peds.2006-0287","article-title":"The Alaska Haemophilus influenzae type b experience: lessons in controlling a vaccine-preventable disease","volume":"118","author":"Singleton","year":"2006","journal-title":"Pediatrics"},{"key":"R52","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.smim.2004.08.013","article-title":"Generation and maintenance of immunological memory","volume":"16","author":"Gourley","year":"2004","journal-title":"Semin Immunol"},{"key":"R53","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1111\/j.1749-6632.1995.tb44461.x","article-title":"Laboratory correlates of protection against Haemophilus influenzae type b disease. Importance of assessment of antibody avidity and immunologic memory","volume":"754","author":"Granoff","year":"1995","journal-title":"Ann N Y Acad Sci"},{"key":"R54","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1084\/jem.163.2.262","article-title":"Oligosaccharide-protein conjugate vaccines induce and prime for oligoclonal IgG antibody responses to the Haemophilus influenzae b capsular polysaccharide in human infants","volume":"163","author":"Insel","year":"1986","journal-title":"J Exp Med"},{"key":"R55","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1086\/517407","article-title":"Antibody avidity as a surrogate marker of successful priming by Haemophilus influenzae type b conjugate vaccines following infant immunization","volume":"177","author":"Goldblatt","year":"1998","journal-title":"J Infect Dis"},{"key":"R56","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1086\/314901","article-title":"The induction of immunologic memory after vaccination with Haemophilus influenzae type b conjugate and acellular pertussis-containing diphtheria, tetanus, and pertussis vaccine combination","volume":"180","author":"Goldblatt","year":"1999","journal-title":"J Infect Dis"},{"key":"R57","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1007\/s004310050544","article-title":"Evidence for induction of polysaccharide specific B-cell-memory in the 1st year of life: plain Haemophilus influenzae type b-PRP (Hib) boosters children primed with a tetanus-conjugate Hib-DTPa-HBV combined vaccine","volume":"156","author":"Zepp","year":"1997","journal-title":"Eur J Pediatr"},{"key":"R58","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1093\/infdis\/168.3.663","article-title":"Induction of immunologic memory in infants primed with Haemophilus influenzae type b conjugate vaccines","volume":"168","author":"Granoff","year":"1993","journal-title":"J Infect Dis"},{"key":"R59","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1097\/00006454-200007000-00001","article-title":"A high degree of natural immunologic priming to the capsular polysaccharide may not prevent Haemophilus influenzae type b meningitis","volume":"19","author":"Anderson","year":"2000","journal-title":"Pediatr Infect Dis J"},{"key":"R60","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1086\/376997","article-title":"Estimating Haemophilus influenzae type b vaccine effectiveness in England and Wales by use of the screening method","volume":"188","author":"Ramsay","year":"2003","journal-title":"J Infect Dis"},{"key":"R61","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1016\/S0140-6736(03)13171-6","article-title":"Risk of vaccine failure after Haemophilus influenzae type b (Hib) combination vaccines with acellular pertussis","volume":"361","author":"McVernon","year":"2003","journal-title":"Lancet"},{"key":"R62","doi-asserted-by":"crossref","first-page":"2334","DOI":"10.1001\/jama.284.18.2334","article-title":"Antibody concentration and clinical protection after Hib conjugate vaccination in the United Kingdom","volume":"284","author":"Heath","year":"2000","journal-title":"JAMA"},{"key":"R63","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1086\/516154","article-title":"Administration of combined diphtheria and tetanus toxoids and pertussis vaccine, hepatitis B vaccine, and Haemophilus influenzae type b (Hib) vaccine to infants and response to a booster dose of Hib conjugate vaccine","volume":"25","author":"Pichichero","year":"1997","journal-title":"Clin Infect Dis"},{"key":"R64","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1093\/cid\/cir538","article-title":"Kinetics of the antibody response to tetanus-diphtheria-acellular pertussis vaccine in women of childbearing age and postpartum women","volume":"53","author":"Halperin","year":"2011","journal-title":"Clin Infect Dis"},{"key":"R65","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1093\/cid\/cir198","article-title":"Kinetics of immune responses to nasal challenge with meningococcal polysaccharide one year after serogroup-C glycoconjugate vaccination","volume":"52","author":"Wing","year":"2011","journal-title":"Clin Infect Dis"},{"key":"R66","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1086\/524668","article-title":"Haemophilus influenzae type b vaccine failure in children is associated with inadequate production of high-quality antibody","volume":"46","author":"Lee","year":"2008","journal-title":"Clin Infect Dis"},{"key":"R67","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1086\/589862","article-title":"Vaccines: correlates of vaccine-induced immunity","volume":"47","author":"Plotkin","year":"2008","journal-title":"Clin Infect Dis"},{"key":"R68","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1542\/peds.2008-3645","article-title":"Booster vaccinations: can immunologic memory outpace disease pathogenesis?","volume":"124","author":"Pichichero","year":"2009","journal-title":"Pediatrics"},{"key":"R69","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1086\/509619","article-title":"Clinical and immunologic risk factors for meningococcal C conjugate vaccine failure in the United Kingdom","volume":"194","author":"Auckland","year":"2006","journal-title":"J Infect Dis"},{"key":"R70","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1086\/652765","article-title":"Antibody persistence after serogroup C meningococcal conjugate immunization of United Kingdom primary-school children in 1999-2000 and response to a booster: a phase 4 clinical trial","volume":"50","author":"Perrett","year":"2010","journal-title":"Clin Infect Dis"},{"key":"R71","doi-asserted-by":"crossref","first-page":"2165","DOI":"10.4049\/jimmunol.180.4.2165","article-title":"The magnitude of the antibody and memory B cell responses during priming with a protein-polysaccharide conjugate vaccine in human infants is associated with the persistence of antibody and the intensity of booster response","volume":"180","author":"Blanchard Rohner","year":"2008","journal-title":"J Immunol"},{"key":"R72","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1128\/CVI.00384-09","article-title":"Kinetics of antibody persistence following administration of a combination meningococcal serogroup C and haemophilus influenzae type b conjugate vaccine in healthy infants in the United Kingdom primed with a monovalent meningococcal serogroup C vaccine","volume":"17","author":"Borrow","year":"2010","journal-title":"Clin Vaccine Immunol"},{"key":"R73","doi-asserted-by":"crossref","first-page":"881","DOI":"10.4161\/hv.6.11.12849","article-title":"Persistence of immune responses after a single dose of Novartis meningococcal serogroup A, C, W-135 and Y CRM-197 conjugate vaccine (Menveo\u00ae) or Menactra\u00ae among healthy adolescents","volume":"6","author":"Gill","year":"2010","journal-title":"Hum Vaccin"},{"key":"R74","doi-asserted-by":"crossref","first-page":"e203","DOI":"10.1097\/INF.0b013e318224fb14","article-title":"Persistence of serum bactericidal antibody one year after a booster dose of either a glycoconjugate or a plain polysaccharide vaccine against serogroup C Neisseria meningitidis given to adolescents previously immunized with a glycoconjugate vaccine","volume":"30","author":"de Whalley","year":"2011","journal-title":"Pediatr Infect Dis J"},{"key":"R75","doi-asserted-by":"crossref","first-page":"e24","DOI":"10.1097\/INF.0b013e318242460a","article-title":"Antibody persistence after a primary series of a new DTaP-IPV-Hep B-PRP-T combined vaccine or separate DTaP-IPV\/\/PRP-T and hepatitis B vaccines at 2, 4, and 6 months of age and the effect of a subsequent DTaP-IPV\/\/PRP-T booster vaccination at 18 months of age in healthy Argentinean infants","volume":"31","author":"Tregnaghi","year":"2012","journal-title":"Pediatr Infect Dis J"},{"key":"R76","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1097\/INF.0b013e3182787bff","article-title":"Three-year antibody persistence and safety after a single dose of combined haemophilus influenzae type b (Hib)-Neisseria meningitidis serogroup C-tetanus toxoid conjugate vaccine in Hib-primed toddlers","volume":"32","author":"Booy","year":"2013","journal-title":"Pediatr Infect Dis J"},{"key":"R77","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/S0022-3476(96)80130-2","article-title":"Immunogenicity of heptavalent pneumococcal conjugate vaccine in infants","volume":"128","author":"Anderson","year":"1996","journal-title":"J Pediatr"},{"key":"R78","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1097\/00006454-199711000-00010","article-title":"Safety and immunogenicity of tetravalent pneumococcal vaccines containing 6B, 14, 19F and 23F polysaccharides conjugated to either tetanus toxoid or diphtheria toxoid in young infants and their boosterability by native polysaccharide antigens","volume":"16","author":"Dagan","year":"1997","journal-title":"Pediatr Infect Dis J"},{"key":"R79","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1097\/00006454-199803000-00008","article-title":"Streptococcus pneumoniae capsular polysaccharide-diphtheria toxoid conjugate vaccine is immunogenic in early infancy and able to induce immunologic memory","volume":"17","author":"Ahman","year":"1998","journal-title":"Pediatr Infect Dis J"},{"key":"R80","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1542\/peds.101.4.604","article-title":"Safety and immunogenicity of heptavalent pneumococcal vaccine conjugated to CRM197 in United States infants","volume":"101","author":"Rennels","year":"1998","journal-title":"Pediatrics"},{"key":"R81","doi-asserted-by":"crossref","first-page":"e31","DOI":"10.1097\/INF.0b013e3182323ac2","article-title":"Induction of immunologic memory following primary vaccination with the 10-valent pneumococcal nontypeable Haemophilus influenzae protein D conjugate vaccine in infants","volume":"31","author":"Knuf","year":"2012","journal-title":"Pediatr Infect Dis J"},{"key":"R82","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1093\/infdis\/175.1.200","article-title":"Induction of immunologic memory in Gambian children by vaccination in infancy with a group A plus group C meningococcal polysaccharide-protein conjugate vaccine","volume":"175","author":"Leach","year":"1997","journal-title":"J Infect Dis"},{"key":"R83","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1001\/jama.280.19.1685","article-title":"Induction of immunologic memory by conjugated vs plain meningococcal C polysaccharide vaccine in toddlers: a randomized controlled trial","volume":"280","author":"MacDonald","year":"1998","journal-title":"JAMA"},{"key":"R84","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1086\/314753","article-title":"Meningococcal serogroup C conjugate vaccine is immunogenic in infancy and primes for memory","volume":"179","author":"Richmond","year":"1999","journal-title":"J Infect Dis"},{"key":"R85","doi-asserted-by":"crossref","first-page":"2795","DOI":"10.1001\/jama.283.21.2795","article-title":"Safety, immunogenicity, and induction of immunologic memory by a serogroup C meningococcal conjugate vaccine in infants: A randomized controlled trial","volume":"283","author":"MacLennan","year":"2000","journal-title":"JAMA"},{"key":"R86","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1086\/317646","article-title":"Ability of 3 different meningococcal C conjugate vaccines to induce immunologic memory after a single dose in UK toddlers","volume":"183","author":"Richmond","year":"2001","journal-title":"J Infect Dis"},{"key":"R87","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1086\/317667","article-title":"Immunologic memory 5 years after meningococcal A\/C conjugate vaccination in infancy","volume":"183","author":"MacLennan","year":"2001","journal-title":"J Infect Dis"},{"key":"R88","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1086\/344324","article-title":"Antibody persistence and immunological memory at age 4 years after meningococcal group C conjugate vaccination in children in the United kingdom","volume":"186","author":"Borrow","year":"2002","journal-title":"J Infect Dis"},{"key":"R89","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1097\/00006454-200208000-00010","article-title":"Safety and immunogenicity of meningococcus serogroup C conjugate vaccine administered as a primary or booster vaccination to healthy four-year-old children","volume":"21","author":"McVernon","year":"2002","journal-title":"Pediatr Infect Dis J"},{"key":"R90","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1097\/01.inf.0000076386.52719.b3","article-title":"Immunologic memory with no detectable bactericidal antibody response to a first dose of meningococcal serogroup C conjugate vaccine at four years","volume":"22","author":"McVernon","year":"2003","journal-title":"Pediatr Infect Dis J"},{"key":"R91","doi-asserted-by":"crossref","first-page":"5549","DOI":"10.1128\/IAI.71.10.5549-5555.2003","article-title":"Immunogenicity of, and immunologic memory to, a reduced primary schedule of meningococcal C-tetanus toxoid conjugate vaccine in infants in the United kingdom","volume":"71","author":"Borrow","year":"2003","journal-title":"Infect Immun"},{"key":"R92","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1001\/archpedi.159.10.907","article-title":"Safety, immunogenicity, and immune memory of a novel meningococcal (groups A, C, Y, and W-135) polysaccharide diphtheria toxoid conjugate vaccine (MCV-4) in healthy adolescents","volume":"159","author":"Keyserling","year":"2005","journal-title":"Arch Pediatr Adolesc Med"},{"key":"R93","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1097\/01.inf.0000243215.46312.4a","article-title":"Immune memory in children previously vaccinated with an experimental quadrivalent meningococcal polysaccharide diphtheria toxoid conjugate vaccine","volume":"25","author":"Pichichero","year":"2006","journal-title":"Pediatr Infect Dis J"},{"key":"R94","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1093\/infdis\/142.5.694","article-title":"Breast milk antibody to the capsular polysaccharide of Haemophilus influenzae type b","volume":"142","author":"Pichichero","year":"1980","journal-title":"J Infect Dis"},{"key":"R95","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1172\/JCI110178","article-title":"A mucosal antibody response following systemic Haemophilus influenzae type B infection in children","volume":"67","author":"Pichichero","year":"1981","journal-title":"J Clin Invest"},{"key":"R96","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1093\/infdis\/146.2.243","article-title":"Relationship between naturally occurring human mucosal and serum antibody to the capsular polysaccharide of Haemophilus influenzae type b","volume":"146","author":"Pichichero","year":"1982","journal-title":"J Infect Dis"},{"key":"R97","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/0091-6749(83)90585-7","article-title":"Mucosal antibody response to parenteral vaccination with Haemophilus influenzae type b capsule","volume":"72","author":"Pichichero","year":"1983","journal-title":"J Allergy Clin Immunol"},{"key":"R98","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/S0264-410X(97)00162-X","article-title":"Circulating antibody secreting cell response to parenteral pneumococcal vaccines as an indicator of a salivary IgA antibody response","volume":"16","author":"Nieminen","year":"1998","journal-title":"Vaccine"},{"key":"R99","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1016\/S0264-410X(97)00235-1","article-title":"Pneumococcal conjugate vaccination in adults: circulating antibody secreting cell response and humoral antibody responses in saliva and in serum","volume":"16","author":"Nieminen","year":"1998","journal-title":"Vaccine"},{"key":"R100","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1097\/00006454-199909000-00005","article-title":"Pneumococcal conjugate vaccination in toddlers: mucosal antibody response measured as circulating antibody-secreting cells and as salivary antibodies","volume":"18","author":"Nieminen","year":"1999","journal-title":"Pediatr Infect Dis J"},{"key":"R101","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1016\/S0264-410X(99)00393-X","article-title":"Salivary anti-capsular antibodies in infants and children immunised with Streptococcus pneumoniae capsular polysaccharides conjugated to diphtheria or tetanus toxoid","volume":"18","author":"Korkeila","year":"2000","journal-title":"Vaccine"},{"key":"R102","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1086\/315834","article-title":"Primary and booster salivary antibody responses to a 7-valent pneumococcal conjugate vaccine in infants","volume":"182","author":"Choo","year":"2000","journal-title":"J Infect Dis"},{"key":"R103","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1097\/00006454-200101000-00006","article-title":"Serum and salivary anti-capsular antibodies in infants and children immunized with the heptavalent pneumococcal conjugate vaccine","volume":"20","author":"Nurkka","year":"2001","journal-title":"Pediatr Infect Dis J"},{"key":"R104","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/S0264-410X(01)00250-X","article-title":"Serum and salivary anti-capsular antibodies in infants and children vaccinated with octavalent pneumococcal conjugate vaccines, PncD and PncT","volume":"20","author":"Nurkka","year":"2001","journal-title":"Vaccine"},{"key":"R105","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1086\/344356","article-title":"Induction of functional secretory IgA responses in breast milk, by pneumococcal capsular polysaccharides","volume":"186","author":"Finn","year":"2002","journal-title":"J Infect Dis"},{"key":"R106","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1093\/infdis\/164.5.982","article-title":"Reduction of oropharyngeal carriage of Haemophilus influenzae type b (Hib) in children immunized with an Hib conjugate vaccine","volume":"164","author":"Takala","year":"1991","journal-title":"J Infect Dis"},{"key":"R107","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1093\/infdis\/174.6.1337","article-title":"Mechanism of antibody-mediated reduction of nasopharyngeal colonization by Haemophilus influenzae type b studied in an infant rat model","volume":"174","author":"Kauppi-Korkeila","year":"1996","journal-title":"J Infect Dis"},{"key":"R108","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1097\/00006454-199307000-00010","article-title":"Vaccination with Haemophilus influenzae type b meningococcal protein conjugate vaccine reduces oropharyngeal carriage of Haemophilus influenzae type b among American Indian children","volume":"12","author":"Takala","year":"1993","journal-title":"Pediatr Infect Dis J"},{"key":"R109","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1086\/315870","article-title":"Prevention of Haemophilus influenzae type b colonization by vaccination: correlation with serum anti-capsular IgG concentration","volume":"182","author":"Fernandez","year":"2000","journal-title":"J Infect Dis"},{"key":"R110","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1136\/adc.86.6.396","article-title":"The UK Hib vaccine experience","volume":"86","author":"Heath","year":"2002","journal-title":"Arch Dis Child"},{"key":"R111","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1093\/ije\/29.4.753","article-title":"Estimation of the indirect effect of Haemophilus influenzae type b conjugate vaccine in an American Indian population","volume":"29","author":"Moulton","year":"2000","journal-title":"Int J Epidemiol"},{"key":"R112","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1093\/infdis\/147.6.1100","article-title":"The protective level of serum antibodies to the capsular polysaccharide of Haemophilus influenzae type b","volume":"147","author":"K\u00e4yhty","year":"1983","journal-title":"J Infect Dis"},{"key":"R113","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1086\/431679","article-title":"Serum serotype-specific pneumococcal anticapsular immunoglobulin g concentrations after immunization with a 9-valent conjugate pneumococcal vaccine correlate with nasopharyngeal acquisition of pneumococcus","volume":"192","author":"Dagan","year":"2005","journal-title":"J Infect Dis"},{"key":"R114","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1093\/infdis\/174.6.1271","article-title":"Reduction of nasopharyngeal carriage of pneumococci during the second year of life by a heptavalent conjugate pneumococcal vaccine","volume":"174","author":"Dagan","year":"1996","journal-title":"J Infect Dis"},{"key":"R115","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1086\/513199","article-title":"Anticapsular serum antibody concentration and protection against pneumococcal colonization among children vaccinated with 7-valent pneumococcal conjugate vaccine","volume":"44","author":"Millar","year":"2007","journal-title":"Clin Infect Dis"},{"key":"R116","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1097\/00006454-199711000-00011","article-title":"Reduction of pneumococcal nasopharyngeal carriage in early infancy after immunization with tetravalent pneumococcal vaccines conjugated to either tetanus toxoid or diphtheria toxoid","volume":"16","author":"Dagan","year":"1997","journal-title":"Pediatr Infect Dis J"},{"key":"R117","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1086\/315009","article-title":"Immunogenicity and impact on nasopharyngeal carriage of a nonavalent pneumococcal conjugate vaccine","volume":"180","author":"Mbelle","year":"1999","journal-title":"J Infect Dis"},{"key":"R118","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1086\/339525","article-title":"Reduction of nasopharyngeal carriage of Streptococcus pneumoniae after administration of a 9-valent pneumococcal conjugate vaccine to toddlers attending day care centers","volume":"185","author":"Dagan","year":"2002","journal-title":"J Infect Dis"},{"key":"R119","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1097\/01.inf.0000069760.65826.f2","article-title":"Vaccination of day-care center attendees reduces carriage of Streptococcus pneumoniae among their younger siblings","volume":"22","author":"Givon-Lavi","year":"2003","journal-title":"Pediatr Infect Dis J"},{"key":"R120","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1097\/01.inf.0000069761.11093.c3","article-title":"Effect of a nonavalent conjugate vaccine on carriage of antibiotic-resistant Streptococcus pneumoniae in day-care centers","volume":"22","author":"Dagan","year":"2003","journal-title":"Pediatr Infect Dis J"},{"key":"R121","doi-asserted-by":"crossref","first-page":"2031","DOI":"10.1086\/425422","article-title":"Impact of a conjugate vaccine on community-wide carriage of nonsusceptible Streptococcus pneumoniae in Alaska","volume":"190","author":"Moore","year":"2004","journal-title":"J Infect Dis"},{"key":"R122","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1086\/423379","article-title":"Effect of the 7-valent pneumococcal conjugate vaccine on nasopharyngeal colonization by Streptococcus pneumoniae in the first 2 years of life","volume":"39","author":"Ghaffar","year":"2004","journal-title":"Clin Infect Dis"},{"key":"R123","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1097\/01.inf.0000143645.58215.f0","article-title":"Seven valent pneumococcal conjugate vaccine immunization in two Boston communities: changes in serotypes and antimicrobial susceptibility among Streptococcus pneumoniae isolates","volume":"23","author":"Pelton","year":"2004","journal-title":"Pediatr Infect Dis J"},{"key":"R124","doi-asserted-by":"crossref","first-page":"e408","DOI":"10.1542\/peds.2004-2338","article-title":"Post-PCV7 changes in colonizing pneumococcal serotypes in 16 Massachusetts communities, 2001 and 2004","volume":"116","author":"Huang","year":"2005","journal-title":"Pediatrics"},{"key":"R125","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1097\/01.inf.0000187030.83080.8a","article-title":"Nasopharyngeal colonization with heptavalent pneumococcal conjugate vaccine serotypes of Streptococcus pneumoniae with prolonged vaccine dosing intervals","volume":"24","author":"Jones","year":"2005","journal-title":"Pediatr Infect Dis J"},{"key":"R126","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1086\/503805","article-title":"Indirect effect of conjugate vaccine on adult carriage of Streptococcus pneumoniae: an explanation of trends in invasive pneumococcal disease","volume":"193","author":"Hammitt","year":"2006","journal-title":"J Infect Dis"},{"key":"R127","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1097\/01.inf.0000243163.85163.a8","article-title":"Impact of pneumococcal conjugate vaccine and of reduction of antibiotic use on nasopharyngeal carriage of nonsusceptible pneumococci in children with acute otitis media","volume":"25","author":"Cohen","year":"2006","journal-title":"Pediatr Infect Dis J"},{"key":"R128","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1097\/INF.0b013e31817bb8cf","article-title":"Trends in nasopharyngeal carriage of Streptococcus pneumoniae among children attending daycare centers in southeastern France from 1999 to 2006","volume":"27","author":"Dunais","year":"2008","journal-title":"Pediatr Infect Dis J"},{"key":"R129","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1086\/591966","article-title":"Indirect effect of 7-valent pneumococcal conjugate vaccine on pneumococcal colonization among unvaccinated household members","volume":"47","author":"Millar","year":"2008","journal-title":"Clin Infect Dis"},{"key":"R130","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1097\/INF.0b013e3181a78185","article-title":"Nasopharyngeal carriage of Streptococcus pneumoniae in Gambian children who participated in a 9-valent pneumococcal conjugate vaccine trial and in their younger siblings","volume":"28","author":"Cheung","year":"2009","journal-title":"Pediatr Infect Dis J"},{"key":"R131","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1542\/peds.2008-3099","article-title":"Continued impact of pneumococcal conjugate vaccine on carriage in young children","volume":"124","author":"Huang","year":"2009","journal-title":"Pediatrics"},{"key":"R132","doi-asserted-by":"crossref","first-page":"584","DOI":"10.3201\/eid1704.101115","article-title":"Carriage of Streptococcus pneumoniae 3 years after start of vaccination program, the Netherlands","volume":"17","author":"Spijkerman","year":"2011","journal-title":"Emerg Infect Dis"},{"key":"R133","doi-asserted-by":"crossref","first-page":"5390","DOI":"10.1016\/j.vaccine.2007.04.088","article-title":"Herd immunity and pneumococcal conjugate vaccine: a quantitative model","volume":"25","author":"Haber","year":"2007","journal-title":"Vaccine"},{"key":"R134","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1097\/INF.0b013e318247ef84","article-title":"Impact of 13-valent pneumococcal conjugate vaccine on pneumococcal nasopharyngeal carriage in children with acute otitis media","volume":"31","author":"Cohen","year":"2012","journal-title":"Pediatr Infect Dis J"},{"key":"R135","doi-asserted-by":"crossref","first-page":"2491","DOI":"10.1001\/jama.292.20.2491","article-title":"Effectiveness of a mass immunization campaign using serogroup C meningococcal conjugate vaccine","volume":"292","author":"De Wals","year":"2004","journal-title":"JAMA"},{"key":"R136","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/S0140-6736(04)16725-1","article-title":"Effectiveness of meningococcal serogroup C conjugate vaccine 4 years after introduction","volume":"364","author":"Trotter","year":"2004","journal-title":"Lancet"},{"key":"R137","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1136\/bmj.326.7385.365","article-title":"Herd immunity from meningococcal serogroup C conjugate vaccination in England: database analysis","volume":"326","author":"Ramsay","year":"2003","journal-title":"BMJ"},{"key":"R138","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1016\/S0140-6736(02)08679-8","article-title":"Carriage of serogroup C meningococci 1 year after meningococcal C conjugate polysaccharide vaccination","volume":"359","author":"Maiden","year":"2002","journal-title":"Lancet"},{"key":"R139","doi-asserted-by":"crossref","first-page":"1959","DOI":"10.1016\/j.vaccine.2010.12.086","article-title":"Impact of the 10-valent pneumococcal non-typeable Haemophilus influenzae Protein D conjugate vaccine (PHiD-CV) on bacterial nasopharyngeal carriage","volume":"29","author":"Prymula","year":"2011","journal-title":"Vaccine"},{"key":"R140","doi-asserted-by":"crossref","first-page":"e30","DOI":"10.1093\/cid\/cis922","article-title":"Effects of the 10-valent pneumococcal nontypeable Haemophilus influenzae protein D-conjugate vaccine on nasopharyngeal bacterial colonization in young children: a randomized controlled trial","volume":"56","author":"van den Bergh","year":"2013","journal-title":"Clin Infect Dis"},{"key":"R141","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1001\/jama.1992.03480110065035","article-title":"Avidity and bactericidal activity of antibody elicited by different Haemophilus influenzae type b conjugate vaccines","volume":"267","author":"Schlesinger","year":"1992","journal-title":"JAMA"},{"key":"R142","doi-asserted-by":"crossref","first-page":"4195","DOI":"10.4049\/jimmunol.154.8.4195","article-title":"Functional differences in idiotypically defined IgG1 anti-polysaccharide antibodies elicited by vaccination with Haemophilus influenzae type B polysaccharide-protein conjugates","volume":"154","author":"Lucas","year":"1995","journal-title":"J Immunol"},{"key":"R143","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1097\/01.inf.0000129686.12470.e6","article-title":"Protective activity of group C anticapsular antibodies elicited in two-year-olds by an investigational quadrivalent Neisseria meningitidis-diphtheria toxoid conjugate vaccine","volume":"23","author":"Granoff","year":"2004","journal-title":"Pediatr Infect Dis J"},{"key":"R144","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0065-2776(08)60414-9","article-title":"Cell selection by antigen in the immune response","volume":"10","author":"Siskind","year":"1969","journal-title":"Adv Immunol"},{"key":"R145","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1128\/CVI.00154-07","article-title":"Quality of the Haemophilus influenzae type b (Hib) antibody response induced by diphtheria-tetanus-acellular pertussis\/Hib combination vaccines","volume":"14","author":"Deno\u00ebl","year":"2007","journal-title":"Clin Vaccine Immunol"},{"key":"R146","doi-asserted-by":"crossref","first-page":"2366","DOI":"10.1128\/IAI.67.5.2366-2370.1999","article-title":"Avidity as a determinant of the protective efficacy of human antibodies to pneumococcal capsular polysaccharides","volume":"67","author":"Usinger","year":"1999","journal-title":"Infect Immun"},{"key":"R147","doi-asserted-by":"crossref","first-page":"1970","DOI":"10.1016\/S0264-410X(98)00458-7","article-title":"Differences in the avidity of antibodies evoked by four different pneumococcal conjugate vaccines in early childhood","volume":"17","author":"Anttila","year":"1999","journal-title":"Vaccine"},{"key":"R148","doi-asserted-by":"crossref","first-page":"1794","DOI":"10.1128\/IAI.01673-06","article-title":"Functional antibodies elicited by two heptavalent pneumococcal conjugate vaccines in the Finnish Otitis Media Vaccine Trial","volume":"75","author":"Ekstr\u00f6m","year":"2007","journal-title":"Infect Immun"},{"key":"R149","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1093\/infdis\/174.6.1360","article-title":"Conjugate meningococcal serogroup A and C vaccine: reactogenicity and immunogenicity in United Kingdom infants","volume":"174","author":"Fairley","year":"1996","journal-title":"J Infect Dis"},{"key":"R150","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1097\/00006454-200002000-00013","article-title":"Safety and immunogenicity of three doses of a Neisseria meningitidis A + C diphtheria conjugate vaccine in infants from Niger","volume":"19","author":"Campagne","year":"2000","journal-title":"Pediatr Infect Dis J"},{"key":"R151","doi-asserted-by":"crossref","first-page":"S58","DOI":"10.1016\/S0264-410X(01)00299-7","article-title":"Planning, registration, and implementation of an immunisation campaign against meningococcal serogroup C disease in the UK: a success story","volume":"20","author":"Miller","year":"2001","journal-title":"Vaccine"},{"key":"R152","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/S0140-6736(00)03594-7","article-title":"Efficacy of meningococcal serogroup C conjugate vaccine in teenagers and toddlers in England","volume":"357","author":"Ramsay","year":"2001","journal-title":"Lancet"},{"key":"R153","doi-asserted-by":"crossref","first-page":"4337","DOI":"10.1128\/IAI.69.7.4337-4341.2001","article-title":"Primary and booster mucosal immune responses to meningococcal group A and C conjugate and polysaccharide vaccines administered to university students in the United Kingdom","volume":"69","author":"Zhang","year":"2001","journal-title":"Infect Immun"},{"key":"R154","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1097\/00006454-200102000-00007","article-title":"Safety and immunogenicity of four doses of Neisseria meningitidis group C vaccine conjugated to CRM197 in United States infants","volume":"20","author":"Rennels","year":"2001","journal-title":"Pediatr Infect Dis J"},{"key":"R155","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1086\/368358","article-title":"Immunogenicity and immunological priming of the serogroup a portion of a bivalent meningococcal A\/C conjugate vaccine in 2-year-old children","volume":"187","author":"Joseph","year":"2003","journal-title":"J Infect Dis"},{"key":"R156","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1086\/428729","article-title":"Effectiveness of serogroup C meningococcal polysaccharide vaccine: results from a case-control study in Quebec","volume":"40","author":"De Wals","year":"2005","journal-title":"Clin Infect Dis"},{"key":"R157","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1099\/jmm.0.46288-0","article-title":"Epidemiology of meningococcal disease in England and Wales 1993\/94 to 2003\/04: contribution and experiences of the Meningococcal Reference Unit","volume":"55","author":"Gray","year":"2006","journal-title":"J Med Microbiol"},{"key":"R158","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1097\/01.inf.0000195594.41449.c6","article-title":"Protection from routine vaccination at the age of 14 months with meningococcal serogroup C conjugate vaccine in the Netherlands","volume":"25","author":"de Greeff","year":"2006","journal-title":"Pediatr Infect Dis J"},{"key":"R159","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1086\/508776","article-title":"Serogroup C meningococcal glycoconjugate vaccine in adolescents: persistence of bactericidal antibodies and kinetics of the immune response to a booster vaccine more than 3 years after immunization","volume":"43","author":"Snape","year":"2006","journal-title":"Clin Infect Dis"},{"key":"R160","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1111\/j.1574-6976.2006.00060.x","article-title":"A surveillance network for meningococcal disease in Europe","volume":"31","author":"Trotter","year":"2007","journal-title":"FEMS Microbiol Rev"},{"key":"R161","doi-asserted-by":"crossref","first-page":"A101","DOI":"10.1016\/j.vaccine.2007.04.050","article-title":"Safety, immunogenicity, and antibody persistence of a new meningococcal group A conjugate vaccine in healthy Indian adults","volume":"25","author":"Kshirsagar","year":"2007","journal-title":"Vaccine"},{"key":"R162","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1086\/527401","article-title":"Impact of meningococcal serogroup C conjugate vaccines on carriage and herd immunity","volume":"197","author":"Maiden","year":"2008","journal-title":"J Infect Dis"},{"key":"R163","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1097\/INF.0b013e31819040e7","article-title":"The impact of childhood meningococcal serogroup C conjugate vaccine programs in Canada","volume":"28","author":"Bettinger","year":"2009","journal-title":"Pediatr Infect Dis J"},{"key":"R164","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1097\/INF.0b013e31820e8638","article-title":"Effectiveness of serogroup C meningococcal conjugate vaccine: a 7-year follow-up in Quebec, Canada","volume":"30","author":"De Wals","year":"2011","journal-title":"Pediatr Infect Dis J"},{"key":"R165","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1097\/00006454-199605000-00009","article-title":"Immunologic priming of young children by pneumococcal glycoprotein conjugate, but not polysaccharide, vaccines","volume":"15","author":"O\u2019Brien","year":"1996","journal-title":"Pediatr Infect Dis J"},{"key":"R166","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1128\/IAI.65.1.242-247.1997","article-title":"Comparison of pneumococcal polysaccharide and CRM197-conjugated pneumococcal oligosaccharide vaccines in young and elderly adults","volume":"65","author":"Shelly","year":"1997","journal-title":"Infect Immun"},{"key":"R167","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1097\/00006454-199701000-00016","article-title":"Evaluation of a pentavalent conjugated pneumococcal vaccine in toddlers","volume":"16","author":"Pichichero","year":"1997","journal-title":"Pediatr Infect Dis J"},{"key":"R168","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S0264-410X(97)00146-1","article-title":"Serum antibody responses of weanling mice and two-year-old children to pneumococcal-type 6A-protein conjugate vaccines of differing saccharide chain lengths","volume":"16","author":"Pichichero","year":"1998","journal-title":"Vaccine"},{"key":"R169","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1093\/infdis\/172.5.1273","article-title":"Pneumococcal polysaccharide-meningococcal outer membrane protein complex conjugate vaccine is immunogenic in infants and children","volume":"172","author":"K\u00e4yhty","year":"1995","journal-title":"J Infect Dis"},{"key":"R170","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1097\/00006454-199602000-00009","article-title":"Pentavalent pneumococcal oligosaccharide conjugate vaccine PncCRM is well-tolerated and able to induce an antibody response in infants","volume":"15","author":"Ahman","year":"1996","journal-title":"Pediatr Infect Dis J"},{"key":"R171","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1086\/514063","article-title":"Infant immunization with pneumococcal CRM197 vaccines: effect of saccharide size on immunogenicity and interactions with simultaneously administered vaccines","volume":"176","author":"Daum","year":"1997","journal-title":"J Infect Dis"},{"key":"R172","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1097\/00006454-199909000-00004","article-title":"Safety and immunogenicity of heptavalent pneumococcal CRM197 conjugate vaccine in infants and toddlers","volume":"18","author":"Shinefield","year":"1999","journal-title":"Pediatr Infect Dis J"},{"key":"R173","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1097\/00006454-200003000-00003","article-title":"Efficacy, safety and immunogenicity of heptavalent pneumococcal conjugate vaccine in children","volume":"19","author":"Black","year":"2000","journal-title":"Pediatr Infect Dis J"},{"key":"R174","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1097\/00006454-200009000-00009","article-title":"Immunogenicity and reactogenicity of a pneumococcal conjugate vaccine administered combined with a haemophilus influenzae type B conjugate vaccine in United Kingdom infants","volume":"19","author":"Choo","year":"2000","journal-title":"Pediatr Infect Dis J"},{"key":"R175","doi-asserted-by":"crossref","first-page":"3653","DOI":"10.1016\/S0264-410X(03)00389-X","article-title":"The safety, reactogenicity and immunogenicity of a 7-valent pneumococcal conjugate vaccine (7VPnC) concurrently administered with a combination DTaP-IPV-Hib vaccine","volume":"21","author":"Schmitt","year":"2003","journal-title":"Vaccine"},{"key":"R176","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1097\/01.inf.0000151022.92222.be","article-title":"Immunogenicity and tolerability of a heptavalent pneumococcal conjugate vaccine administered at 3, 5 and 12 months of age","volume":"24","author":"K\u00e4yhty","year":"2005","journal-title":"Pediatr Infect Dis J"},{"key":"R177","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1542\/peds.2009-1405","article-title":"Safety and immunogenicity of a 13-valent pneumococcal conjugate vaccine","volume":"125","author":"Bryant","year":"2010","journal-title":"Pediatrics"},{"key":"R178","doi-asserted-by":"crossref","first-page":"4192","DOI":"10.1016\/j.vaccine.2010.04.008","article-title":"Safety, tolerability, and immunologic noninferiority of a 13-valent pneumococcal conjugate vaccine compared to a 7-valent pneumococcal conjugate vaccine given with routine pediatric vaccinations in Germany","volume":"28","author":"Kieninger","year":"2010","journal-title":"Vaccine"},{"key":"R179","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1128\/CVI.00062-10","article-title":"Safety and immunogenicity of a 13-valent pneumococcal conjugate vaccine compared to those of a 7-valent pneumococcal conjugate vaccine given as a three-dose series with routine vaccines in healthy infants and toddlers","volume":"17","author":"Esposito","year":"2010","journal-title":"Clin Vaccine Immunol"},{"key":"R180","doi-asserted-by":"crossref","first-page":"e493","DOI":"10.1542\/peds.2009-3027","article-title":"Immunogenicity and safety of 13-valent pneumococcal conjugate vaccine in infants and toddlers","volume":"126","author":"Yeh","year":"2010","journal-title":"Pediatrics"},{"key":"R181","doi-asserted-by":"crossref","first-page":"e80","DOI":"10.1097\/INF.0b013e3181faa6be","article-title":"Immunogenicity and reactogenicity of a 13-valent-pneumococcal conjugate vaccine administered at 2, 4, and 12 months of age: a double-blind randomized active-controlled trial","volume":"29","author":"Snape","year":"2010","journal-title":"Pediatr Infect Dis J"},{"key":"R182","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1097\/INF.0b013e318233049d","article-title":"Safety and immunogenicity of a 13-valent pneumococcal conjugate vaccine in healthy infants and toddlers given with routine pediatric vaccinations in Canada","volume":"31","author":"Vanderkooi","year":"2012","journal-title":"Pediatr Infect Dis J"},{"key":"R183","doi-asserted-by":"crossref","first-page":"2054","DOI":"10.1016\/j.vaccine.2011.12.054","article-title":"Immunogenicity and safety of a 13-valent pneumococcal conjugate vaccine given with routine pediatric vaccines in Taiwan","volume":"30","author":"Huang","year":"2012","journal-title":"Vaccine"},{"key":"R184","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1097\/INF.0b013e31827b478d","article-title":"Immunogenicity and Safety of a 13-Valent Pneumococcal Conjugate Vaccine in Healthy Infants and Toddlers Given With Routine Vaccines in India","volume":"32","author":"Amdekar","year":"2013","journal-title":"Pediatr Infect Dis J"},{"key":"R185","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1097\/00006454-200112000-00002","article-title":"Postlicensure evaluation of the effectiveness of seven valent pneumococcal conjugate vaccine","volume":"20","author":"Black","year":"2001","journal-title":"Pediatr Infect Dis J"},{"key":"R186","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1097\/00006454-200209000-00005","article-title":"Effectiveness of heptavalent pneumococcal conjugate vaccine in children younger than five years of age for prevention of pneumonia","volume":"21","author":"Black","year":"2002","journal-title":"Pediatr Infect Dis J"},{"key":"R187","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1056\/NEJMoa022823","article-title":"Decline in invasive pneumococcal disease after the introduction of protein-polysaccharide conjugate vaccine","volume":"348","author":"Whitney","year":"2003","journal-title":"N Engl J Med"},{"key":"R188","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1097\/01.inf.0000129685.04847.94","article-title":"Postlicensure surveillance for pneumococcal invasive disease after use of heptavalent pneumococcal conjugate vaccine in Northern California Kaiser Permanente","volume":"23","author":"Black","year":"2004","journal-title":"Pediatr Infect Dis J"},{"key":"R189","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1016\/S0140-6736(06)69637-2","article-title":"Effectiveness of seven-valent pneumococcal conjugate vaccine against invasive pneumococcal disease: a matched case-control study","volume":"368","author":"Whitney","year":"2006","journal-title":"Lancet"},{"key":"R190","doi-asserted-by":"crossref","first-page":"e45","DOI":"10.1097\/INF.0b013e3182788fdd","article-title":"Pneumococcal carriage and invasive disease in children before introduction of the 13-valent conjugate vaccine: comparison with the era before 7-valent conjugate vaccine","volume":"32","author":"Sharma","year":"2013","journal-title":"Pediatr Infect Dis J"},{"key":"R191","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1001\/jama.2007.29-c","article-title":"Immunogenicity of a tetravalent meningococcal glycoconjugate vaccine in infants: a randomized controlled trial","volume":"299","author":"Snape","year":"2008","journal-title":"JAMA"},{"key":"R192","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1086\/599117","article-title":"Phase III comparison of an investigational quadrivalent meningococcal conjugate vaccine with the licensed meningococcal ACWY conjugate vaccine in adolescents","volume":"49","author":"Jackson","year":"2009","journal-title":"Clin Infect Dis"},{"key":"R193","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1097\/INF.0b013e31818e037d","article-title":"Immunogenicity and immune memory of a nonadjuvanted quadrivalent meningococcal glycoconjugate vaccine in infants","volume":"28","author":"Perrett","year":"2009","journal-title":"Pediatr Infect Dis J"},{"key":"R194","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1097\/INF.0b013e31818a0237","article-title":"A randomized trial to determine the tolerability and immunogenicity of a quadrivalent meningococcal glycoconjugate vaccine in healthy adolescents","volume":"28","author":"Jackson","year":"2009","journal-title":"Pediatr Infect Dis J"},{"key":"R195","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1007\/s10096-009-0848-8","article-title":"Safety and immunogenicity of an investigational quadrivalent meningococcal conjugate vaccine after one or two doses given to infants and toddlers","volume":"29","author":"Halperin","year":"2010","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"R196","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/j.vaccine.2009.10.104","article-title":"Immunogenicity and tolerability of a quadrivalent meningococcal glycoconjugate vaccine in children 2-10 years of age","volume":"28","author":"Black","year":"2010","journal-title":"Vaccine"},{"key":"R197","doi-asserted-by":"crossref","first-page":"3171","DOI":"10.1016\/j.vaccine.2010.02.045","article-title":"Safety and immunogenicity of one dose of MenACWY-CRM, an investigational quadrivalent meningococcal glycoconjugate vaccine, when administered to adolescents concomitantly or sequentially with Tdap and HPV vaccines","volume":"28","author":"Arguedas","year":"2010","journal-title":"Vaccine"},{"key":"R198","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1128\/CVI.00436-09","article-title":"Randomized trial on the safety, tolerability, and immunogenicity of MenACWY-CRM, an investigational quadrivalent meningococcal glycoconjugate vaccine, administered concomitantly with a combined tetanus, reduced diphtheria, and acellular pertussis vaccine in adolescents and young adults","volume":"17","author":"Gasparini","year":"2010","journal-title":"Clin Vaccine Immunol"},{"key":"R199","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1097\/INF.0b013e31823dce5c","article-title":"Safety and immunogenicity of a novel quadrivalent meningococcal CRM-conjugate vaccine given concomitantly with routine vaccinations in infants","volume":"31","author":"Klein","year":"2012","journal-title":"Pediatr Infect Dis J"},{"key":"R200","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1097\/01.inf.0000126297.28952.f8","article-title":"Dosage escalation, safety and immunogenicity study of four dosages of a tetravalent meninogococcal polysaccharide diphtheria toxoid conjugate vaccine in infants","volume":"23","author":"Rennels","year":"2004","journal-title":"Pediatr Infect Dis J"},{"key":"R201","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1097\/01.inf.0000151035.64356.f8","article-title":"Persistence of group C anticapsular antibodies two to three years after immunization with an investigational quadrivalent Neisseria meningitidis-diphtheria toxoid conjugate vaccine","volume":"24","author":"Granoff","year":"2005","journal-title":"Pediatr Infect Dis J"},{"key":"R202","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1097\/01.inf.0000148928.10057.86","article-title":"Comparative trial of the safety and immunogenicity of quadrivalent (A, C, Y, W-135) meningococcal polysaccharide-diphtheria conjugate vaccine versus quadrivalent polysaccharide vaccine in two- to ten-year-old children","volume":"24","author":"Pichichero","year":"2005","journal-title":"Pediatr Infect Dis J"},{"key":"R203","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1097\/INF.0b013e31820a8b3c","article-title":"Early estimate of the effectiveness of quadrivalent meningococcal conjugate vaccine","volume":"30","author":"Macneil","year":"2011","journal-title":"Pediatr Infect Dis J"},{"key":"R204","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1097\/INF.0b013e318268dfe4","article-title":"Safety and immunogenicity of a quadrivalent meningococcal polysaccharide diphtheria toxoid conjugate vaccine in infants and toddlers: three multicenter phase III studies","volume":"31","author":"Pina","year":"2012","journal-title":"Pediatr Infect Dis J"},{"key":"R205","doi-asserted-by":"crossref","first-page":"1848","DOI":"10.1086\/345763","article-title":"Safety, reactogenicity, and immunogenicity of a tetravalent meningococcal polysaccharide-diphtheria toxoid conjugate vaccine given to healthy adults","volume":"186","author":"Campbell","year":"2002","journal-title":"J Infect Dis"},{"key":"R206","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1016\/j.vaccine.2009.10.064","article-title":"A dose-range study assessing immunogenicity and safety of one dose of a new candidate meningococcal serogroups A, C, W-135, Y tetanus toxoid conjugate (MenACWY-TT) vaccine administered in the second year of life and in young children","volume":"28","author":"Knuf","year":"2010","journal-title":"Vaccine"},{"key":"R207","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.vaccine.2008.08.075","article-title":"Immunogenicity, reactogenicity and persistence of meningococcal A, C, W-135 and Y-tetanus toxoid candidate conjugate (MenACWY-TT) vaccine formulations in adolescents aged 15-25 years","volume":"27","author":"Ostergaard","year":"2009","journal-title":"Vaccine"},{"key":"R208","doi-asserted-by":"crossref","first-page":"1882","DOI":"10.4161\/hv.22165","article-title":"A randomized study to assess the immunogenicity, antibody persistence and safety of a tetravalent meningococcal serogroups A, C, W-135 and Y tetanus toxoid conjugate vaccine in children aged 2-10 years","volume":"8","author":"Vesikari","year":"2012","journal-title":"Hum Vaccin Immunother"},{"key":"R209","doi-asserted-by":"crossref","first-page":"4274","DOI":"10.1016\/j.vaccine.2011.03.043","article-title":"Tetravalent meningococcal serogroups A, C, W-135 and Y conjugate vaccine is well tolerated and immunogenic when co-administered with measles-mumps-rubella-varicella vaccine during the second year of life: An open, randomized controlled trial","volume":"29","author":"Vesikari","year":"2011","journal-title":"Vaccine"},{"key":"R210","doi-asserted-by":"crossref","first-page":"e56","DOI":"10.1097\/INF.0b013e31820e6e02","article-title":"Immunogenicity of a single dose of tetravalent meningococcal serogroups A, C, W-135, and Y conjugate vaccine administered to 2- to 10-year-olds is noninferior to a licensed-ACWY polysaccharide vaccine with an acceptable safety profile","volume":"30","author":"Memish","year":"2011","journal-title":"Pediatr Infect Dis J"},{"key":"R211","doi-asserted-by":"crossref","first-page":"e41","DOI":"10.1097\/INF.0b013e3182054ab9","article-title":"Immunogenicity and safety of an investigational quadrivalent meningococcal ACWY tetanus toxoid conjugate vaccine in healthy adolescents and young adults 10 to 25 years of age","volume":"30","author":"Baxter","year":"2011","journal-title":"Pediatr Infect Dis J"},{"key":"R212","doi-asserted-by":"crossref","first-page":"239","DOI":"10.4161\/hv.7.2.14068","article-title":"Safety and immunogenicity of a tetravalent meningococcal serogroups A, C, W-135 and Y conjugate vaccine in adolescents and adults","volume":"7","author":"Bermal","year":"2011","journal-title":"Hum Vaccin"},{"key":"R213","doi-asserted-by":"crossref","first-page":"873","DOI":"10.4161\/hv.20211","article-title":"The immunogenicity and safety of an investigational meningococcal serogroups A, C, W-135, Y tetanus toxoid conjugate vaccine (ACWY-TT) compared with a licensed meningococcal tetravalent polysaccharide vaccine: a randomized, controlled non-inferiority study","volume":"8","author":"Dbaibo","year":"2012","journal-title":"Hum Vaccin Immunother"},{"key":"R214","doi-asserted-by":"crossref","first-page":"258","DOI":"10.4161\/hv.7.2.14170","article-title":"Co-administration of a novel Haemophilus influenzae type b and Neisseria meningitidis serogroups C and Y-tetanus toxoid conjugate vaccine does not interfere with the immune response to antigens contained in infant vaccines routinely used in the United States","volume":"7","author":"Marshall","year":"2011","journal-title":"Hum Vaccin"},{"key":"R215","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1097\/INF.0b013e3181fcb2bf","article-title":"Immunogenicity and safety of an investigational combined haemophilus influenzae type B-Neisseria meningitidis serogroups C and Y-tetanus toxoid conjugate vaccine","volume":"30","author":"Nolan","year":"2011","journal-title":"Pediatr Infect Dis J"},{"key":"R216","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1056\/NEJM200102083440602","article-title":"Efficacy of a pneumococcal conjugate vaccine against acute otitis media","volume":"344","author":"Eskola","year":"2001","journal-title":"N Engl J Med"},{"key":"R217","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/S0140-6736(03)14022-6","article-title":"Efficacy and safety of seven-valent conjugate pneumococcal vaccine in American Indian children: group randomised trial","volume":"362","author":"O\u2019Brien","year":"2003","journal-title":"Lancet"},{"key":"R218","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1086\/378744","article-title":"Protective efficacy of a second pneumococcal conjugate vaccine against pneumococcal acute otitis media in infants and children: randomized, controlled trial of a 7-valent pneumococcal polysaccharide-meningococcal outer membrane protein complex conjugate vaccine in 1666 children","volume":"37","author":"Kilpi","year":"2003","journal-title":"Clin Infect Dis"},{"key":"R219","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1016\/S0140-6736(06)68304-9","article-title":"Pneumococcal capsular polysaccharides conjugated to protein D for prevention of acute otitis media caused by both Streptococcus pneumoniae and non-typable Haemophilus influenzae: a randomised double-blind efficacy study","volume":"367","author":"Prymula","year":"2006","journal-title":"Lancet"},{"key":"R220","doi-asserted-by":"crossref","first-page":"4563","DOI":"10.1016\/j.vaccine.2008.05.080","article-title":"Safety of the 11-valent pneumococcal vaccine conjugated to non-typeable Haemophilus influenzae-derived protein D in the first 2 years of life and immunogenicity of the co-administered hexavalent diphtheria, tetanus, acellular pertussis, hepatitis B, inactivated polio virus, Haemophilus influenzae type b and control hepatitis A vaccines","volume":"26","author":"Prymula","year":"2008","journal-title":"Vaccine"},{"key":"R221","doi-asserted-by":"crossref","first-page":"S97","DOI":"10.1097\/INF.0b013e318199f61b","article-title":"Immunogenicity of routinely used childhood vaccines when coadministered with the 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV)","volume":"28","author":"Knuf","year":"2009","journal-title":"Pediatr Infect Dis J"},{"key":"R222","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/S0140-6736(12)61854-6","article-title":"Effectiveness of the ten-valent pneumococcal Haemophilus influenzae protein D conjugate vaccine (PHiD-CV10) against invasive pneumococcal disease: a cluster randomised trial","volume":"381","author":"Palmu","year":"2013","journal-title":"Lancet"},{"key":"R223","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1097\/00006454-200103000-00011","article-title":"Tolerability and immunogenicity of an eleven-valent pneumococcal conjugate vaccine in healthy toddlers","volume":"20","author":"Wuorimaa","year":"2001","journal-title":"Pediatr Infect Dis J"},{"key":"R224","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1086\/323648","article-title":"Avidity and subclasses of IgG after immunization of infants with an 11-valent pneumococcal conjugate vaccine with or without aluminum adjuvant","volume":"184","author":"Wuorimaa","year":"2001","journal-title":"J Infect Dis"},{"key":"R225","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1097\/00006454-200204000-00010","article-title":"Antibody response to an eleven valent diphtheria- and tetanus-conjugated pneumococcal conjugate vaccine in Filipino infants","volume":"21","author":"Puumalainen","year":"2002","journal-title":"Pediatr Infect Dis J"},{"key":"R226","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1056\/NEJMoa035060","article-title":"A trial of a 9-valent pneumococcal conjugate vaccine in children with and those without HIV infection","volume":"349","author":"Klugman","year":"2003","journal-title":"N Engl J Med"},{"key":"R227","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1097\/01.inf.0000050459.74134.d5","article-title":"Greater antibody responses to an eleven valent mixed carrier diphtheria- or tetanus-conjugated pneumococcal vaccine in Filipino than in Finnish or Israeli infants","volume":"22","author":"Puumalainen","year":"2003","journal-title":"Pediatr Infect Dis J"},{"key":"R228","doi-asserted-by":"crossref","first-page":"1704","DOI":"10.1086\/375242","article-title":"Functional antibodies elicited by an 11-valent diphtheria-tetanus toxoid-conjugated pneumococcal vaccine","volume":"187","author":"Puumalainen","year":"2003","journal-title":"J Infect Dis"},{"key":"R229","doi-asserted-by":"crossref","first-page":"5383","DOI":"10.1128\/IAI.72.9.5383-5391.2004","article-title":"Reduction of antibody response to an 11-valent pneumococcal vaccine coadministered with a vaccine containing acellular pertussis components","volume":"72","author":"Dagan","year":"2004","journal-title":"Infect Immun"},{"key":"R230","doi-asserted-by":"crossref","first-page":"2077","DOI":"10.1086\/420849","article-title":"Similar antibody concentrations in Filipino infants at age 9 months, after 1 or 3 doses of an adjuvanted, 11-valent pneumococcal diphtheria\/tetanus-conjugated vaccine: a randomized controlled trial","volume":"189","author":"Lucero","year":"2004","journal-title":"J Infect Dis"},{"key":"R231","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1097\/01.inf.0000109221.50972.53","article-title":"Tolerability and immunogenicity of an eleven valent mixed carrier Streptococcus pneumoniae capsular polysaccharide-diphtheria toxoid or tetanus protein conjugate vaccine in Finnish and Israeli infants","volume":"23","author":"Dagan","year":"2004","journal-title":"Pediatr Infect Dis J"},{"key":"R232","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1016\/S0140-6736(05)71876-6","article-title":"Efficacy of nine-valent pneumococcal conjugate vaccine against pneumonia and invasive pneumococcal disease in The Gambia: randomised, double-blind, placebo-controlled trial","volume":"365","author":"Cutts","year":"2005","journal-title":"Lancet"},{"key":"R233","doi-asserted-by":"crossref","first-page":"S66","DOI":"10.1097\/INF.0b013e318199f8ef","article-title":"Immunogenicity of the 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) compared to the licensed 7vCRM vaccine","volume":"28","author":"Vesikari","year":"2009","journal-title":"Pediatr Infect Dis J"},{"key":"R234","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1093\/infdis\/173.1.256","article-title":"Pneumococcal conjugate vaccine primes for antibody responses to polysaccharide pneumococcal vaccine after treatment of Hodgkin\u2019s disease","volume":"173","author":"Chan","year":"1996","journal-title":"J Infect Dis"},{"key":"R235","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1097\/00006454-199604000-00010","article-title":"Pilot trial of a pentavalent pneumococcal polysaccharide\/protein conjugate vaccine in Gambian infants","volume":"15","author":"Leach","year":"1996","journal-title":"Pediatr Infect Dis J"},{"key":"R236","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1542\/peds.99.4.575","article-title":"Safety and immunogenicity of three doses of a five-valent pneumococcal conjugate vaccine in children younger than two years with and without human immunodeficiency virus infection","volume":"99","author":"King","year":"1997","journal-title":"Pediatrics"},{"key":"R237","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1097\/00006454-199808000-00005","article-title":"Response to a heptavalent conjugate Streptococcus pneumoniae vaccine in children with recurrent infections who are unresponsive to the polysaccharide vaccine","volume":"17","author":"Sorensen","year":"1998","journal-title":"Pediatr Infect Dis J"},{"key":"R238","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1086\/313907","article-title":"Immunogenicity of a heptavalent pneumococcal conjugate vaccine in Apache and Navajo Indian, Alaska native, and non-native American children aged <2 years","volume":"31","author":"Miernyk","year":"2000","journal-title":"Clin Infect Dis"},{"key":"R239","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1097\/00006454-200005000-00014","article-title":"Safety and immunogenicity of a nonavalent pneumococcal vaccine conjugated to CRM197 administered simultaneously but in a separate syringe with diphtheria, tetanus and pertussis vaccines in Gambian infants","volume":"19","author":"Obaro","year":"2000","journal-title":"Pediatr Infect Dis J"},{"key":"R240","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1097\/00006454-200210000-00011","article-title":"Safety and immunogenicity of pneumococcal conjugate vaccine in combination with diphtheria, tetanus toxoid, pertussis and Haemophilus influenzae type b conjugate vaccine","volume":"21","author":"Obaro","year":"2002","journal-title":"Pediatr Infect Dis J"},{"key":"R241","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1097\/00006454-200211000-00006","article-title":"Immunogenicity after one, two or three doses and impact on the antibody response to coadministered antigens of a nonavalent pneumococcal conjugate vaccine in infants of Soweto, South Africa","volume":"21","author":"Huebner","year":"2002","journal-title":"Pediatr Infect Dis J"},{"key":"R242","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1086\/374784","article-title":"Randomized, double-blind, controlled trial of pneumococcal vaccination in renal transplant recipients","volume":"187","author":"Kumar","year":"2003","journal-title":"J Infect Dis"},{"key":"R243","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1542\/peds.112.1.66","article-title":"Safety and immunogenicity of a heptavalent pneumococcal conjugate vaccine in infants with human immunodeficiency virus type 1 infection","volume":"112","author":"Nachman","year":"2003","journal-title":"Pediatrics"},{"key":"R244","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1086\/597388","article-title":"Quantitative and qualitative anamnestic immune responses to pneumococcal conjugate vaccine in HIV-infected and HIV-uninfected children 5 years after vaccination","volume":"199","author":"Madhi","year":"2009","journal-title":"J Infect Dis"},{"key":"R245","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1086\/598324","article-title":"Randomized study of early versus late immunization with pneumococcal conjugate vaccine after allogeneic stem cell transplantation","volume":"48","author":"Cordonnier","year":"2009","journal-title":"Clin Infect Dis"},{"key":"R246","doi-asserted-by":"crossref","first-page":"3391","DOI":"10.1128\/IAI.62.8.3391-3395.1994","article-title":"Safety and immunogenicity of meningococcal A and C polysaccharide conjugate vaccine in adults","volume":"62","author":"Anderson","year":"1994","journal-title":"Infect Immun"},{"key":"R247","doi-asserted-by":"crossref","first-page":"3402","DOI":"10.1128\/IAI.71.6.3402-3408.2003","article-title":"Disparity in functional activity between serum anticapsular antibodies induced in adults by immunization with an investigational group A and C Neisseria meningitidis-diphtheria toxoid conjugate vaccine and by a polysaccharide vaccine","volume":"71","author":"Harris","year":"2003","journal-title":"Infect Immun"},{"key":"R248","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1086\/591629","article-title":"Initial and subsequent response to pneumococcal polysaccharide and protein-conjugate vaccines administered sequentially to adults who have recovered from pneumococcal pneumonia","volume":"198","author":"Musher","year":"2008","journal-title":"J Infect Dis"},{"key":"R249","doi-asserted-by":"crossref","first-page":"1810","DOI":"10.1128\/CVI.00207-09","article-title":"Quadrivalent meningococcal vaccination of adults: phase III comparison of an investigational conjugate vaccine, MenACWY-CRM, with the licensed vaccine, Menactra","volume":"16","author":"Reisinger","year":"2009","journal-title":"Clin Vaccine Immunol"},{"key":"R250","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1086\/599824","article-title":"Immunogenicity and reactogenicity of pneumococcal polysaccharide and conjugate vaccines in alaska native adults 55-70 years of age","volume":"49","author":"Miernyk","year":"2009","journal-title":"Clin Infect Dis"},{"key":"R251","doi-asserted-by":"crossref","first-page":"e868","DOI":"10.1016\/j.ijid.2010.03.017","article-title":"Safety and immunogenicity of an investigational quadrivalent meningococcal CRM(197) conjugate vaccine, MenACWY-CRM, compared with licensed vaccines in adults in Latin America","volume":"14","author":"Stamboulian","year":"2010","journal-title":"Int J Infect Dis"},{"key":"R252","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1093\/cid\/cir003","article-title":"A randomized study comparing combined pneumococcal conjugate and polysaccharide vaccination schedules in adults","volume":"52","author":"Lazarus","year":"2011","journal-title":"Clin Infect Dis"},{"key":"R253","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/0008-8749(87)90008-6","article-title":"Epitopic suppression in synthetic vaccine models: analysis of the effector mechanisms","volume":"104","author":"Schutze","year":"1987","journal-title":"Cell Immunol"},{"key":"R254","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1038\/285664a0","article-title":"Carrier-priming leads to hapten-specific suppression","volume":"285","author":"Herzenberg","year":"1980","journal-title":"Nature"},{"key":"R255","doi-asserted-by":"crossref","first-page":"2635","DOI":"10.4049\/jimmunol.142.8.2635","article-title":"Carrier-induced epitopic suppression is initiated through clonal dominance","volume":"142","author":"Schutze","year":"1989","journal-title":"J Immunol"},{"key":"R256","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1128\/IAI.59.3.1057-1064.1991","article-title":"Influence of prevaccination immunity on the human B-lymphocyte response to a Haemophilus influenzae type b conjugate vaccine","volume":"59","author":"Barington","year":"1991","journal-title":"Infect Immun"},{"key":"R257","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1128\/IAI.61.2.432-438.1993","article-title":"Non-epitope-specific suppression of the antibody response to Haemophilus influenzae type b conjugate vaccines by preimmunization with vaccine components","volume":"61","author":"Barington","year":"1993","journal-title":"Infect Immun"},{"key":"R258","doi-asserted-by":"crossref","first-page":"2093","DOI":"10.1128\/IAI.66.5.2093-2098.1998","article-title":"Reduced response to multiple vaccines sharing common protein epitopes that are administered simultaneously to infants","volume":"66","author":"Dagan","year":"1998","journal-title":"Infect Immun"},{"key":"R259","doi-asserted-by":"crossref","first-page":"702","DOI":"10.4049\/jimmunol.161.2.702","article-title":"Carrier-induced, hapten-specific suppression: a problem of antigen presentation?","volume":"161","author":"Renjifo","year":"1998","journal-title":"J Immunol"},{"key":"R260","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/S0264-410X(98)00162-5","article-title":"Epitopic overload at the site of injection may result in suppression of the immune response to combined capsular polysaccharide conjugate vaccines","volume":"17","author":"Fattom","year":"1999","journal-title":"Vaccine"},{"key":"R261","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1097\/00006454-200005000-00006","article-title":"Diminution of the anti-polyribosylribitol phosphate response to a combined diphtheria-tetanus-acellular pertussis\/Haemophilus influenzae type b vaccine by concurrent inactivated poliovirus vaccination","volume":"19","author":"Rennels","year":"2000","journal-title":"Pediatr Infect Dis J"},{"key":"R262","first-page":"315","article-title":"Safety and immunogenicity of a diphtheria, tetanus, and acellular pertussis-inactivated poliovirus vaccine\/Haemophilus influenzae type B combination vaccine administered to Taiwanese infants at 2, 4, and 6 months of age","volume":"26","author":"Lin","year":"2003","journal-title":"Chang Gung Med J"},{"key":"R263","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1097\/00006454-199811000-00013","article-title":"Safety and immunogenicity of a combined diphtheria-tetanus-acellular pertussis-inactivated polio vaccine-Haemophilus influenzae type b vaccine administered at 2-4-6-13 or 3-5-12 months of age","volume":"17","author":"Carlsson","year":"1998","journal-title":"Pediatr Infect Dis J"},{"key":"R264","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1097\/00006454-199405000-00004","article-title":"Safety and immunogenicity of Haemophilus influenzae vaccine (tetanus toxoid conjugate) administered concurrently or combined with diphtheria and tetanus toxoids, pertussis vaccine and inactivated poliomyelitis vaccine to healthy infants at two, four and six months of age","volume":"13","author":"Gold","year":"1994","journal-title":"Pediatr Infect Dis J"},{"key":"R265","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/S0264-410X(97)00161-8","article-title":"Randomised controlled trial of combined diphtheria, tetanus, whole-cell pertussis vaccine administered in the same syringe and separately with Haemophilus influenzae type b vaccine at two, three and four months of age","volume":"16","author":"Jones","year":"1998","journal-title":"Vaccine"},{"key":"R266","doi-asserted-by":"crossref","first-page":"4946","DOI":"10.1128\/IAI.70.9.4946-4954.2002","article-title":"Effect of vaccination with carrier protein on response to meningococcal C conjugate vaccines and value of different immunoassays as predictors of protection","volume":"70","author":"Burrage","year":"2002","journal-title":"Infect Immun"},{"key":"R267","first-page":"55","article-title":"Rising incidence of Haemophilus influenzae type b disease in England and Wales indicates a need for a second catch-up vaccination campaign","volume":"6","author":"Trotter","year":"2003","journal-title":"Commun Dis Public Health"},{"key":"R268","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1073\/pnas.94.1.271","article-title":"Capsule switching of Neisseria meningitidis","volume":"94","author":"Swartley","year":"1997","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R269","doi-asserted-by":"crossref","DOI":"10.1128\/JCM.01645-13","article-title":"Capsular gene sequences and genotypes of \u2018serotype 6E\u2019 Streptococcus pneumoniae isolates","author":"Ko","year":"2013","journal-title":"J Clin Microbiol"},{"key":"R270","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.3201\/eid1907.121830","article-title":"Pneumococcal serotypes before and after introduction of conjugate vaccines, United States, 1999-2011(1.)","volume":"19","author":"Richter","year":"2013","journal-title":"Emerg Infect Dis"},{"key":"R271","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.coi.2011.04.002","article-title":"Next generation pneumococcal vaccines","volume":"23","author":"Moffitt","year":"2011","journal-title":"Curr Opin Immunol"},{"key":"R272","doi-asserted-by":"crossref","first-page":"1962","DOI":"10.1016\/S0140-6736(10)62225-8","article-title":"Serotype replacement in disease after pneumococcal vaccination","volume":"378","author":"Weinberger","year":"2011","journal-title":"Lancet"},{"key":"R273","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1093\/infdis\/jir052","article-title":"Shifting genetic structure of invasive serotype 19A pneumococci in the United States","volume":"203","author":"Beall","year":"2011","journal-title":"J Infect Dis"},{"key":"R274","doi-asserted-by":"crossref","first-page":"1772","DOI":"10.1001\/jama.298.15.1772","article-title":"Emergence of a multiresistant serotype 19A pneumococcal strain not included in the 7-valent conjugate vaccine as an otopathogen in children","volume":"298","author":"Pichichero","year":"2007","journal-title":"JAMA"},{"key":"R275","doi-asserted-by":"crossref","first-page":"2359","DOI":"10.1016\/S0264-410X(00)00021-9","article-title":"A comparison of multiple regimens of pneumococcal polysaccharide-meningococcal outer membrane protein complex conjugate vaccine and pneumococcal polysaccharide vaccine in toddlers","volume":"18","author":"Blum","year":"2000","journal-title":"Vaccine"},{"key":"R276","doi-asserted-by":"crossref","first-page":"1894","DOI":"10.1016\/S0264-410X(03)00013-6","article-title":"Safety and immunogenicity of a heptavalent pneumococcal conjugate vaccine in infants","volume":"21","author":"Zangwill","year":"2003","journal-title":"Vaccine"}],"container-title":["Human vaccines &amp; immunotherapeutics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.tandfonline.com\/doi\/pdf\/10.4161\/hv.26109","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,4]],"date-time":"2023-07-04T14:23:38Z","timestamp":1688480618000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.landesbioscience.com\/journals\/vaccines\/article\/26109\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,12,1]]},"references-count":276,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2013,12,1]]}},"URL":"https:\/\/doi.org\/10.4161\/hv.26109","relation":{},"ISSN":["2164-5515","2164-554X"],"issn-type":[{"value":"2164-5515","type":"print"},{"value":"2164-554X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,12,1]]}}}